alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › integrating

integrating

3 studies tagged integrating, dated 2021-08-11 to 2025-03-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Cut-points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practice 2025-03-01
  2. Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brain 2022-03-14
  3. Identification of novel drug targets for Alzheimer's disease by integrating genetics and proteomes from brain and blood 2021-08-11

Studies

3 studies carry this tag.

Date range

2021 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Molecular psychiatry 1
  • Nature neuroscience 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Cut-points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practice

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-03-01 Biomarkers

    Plasma biomarkers for Alzheimer's disease (AD), such as plasma phosphorylated (p)-tau217, offer a more accessible means of testing for the presence of AD pathology compared to cerebrospinal fluid (CSF) or positron emission tomography (PET) methods.

  2. Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brain

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Nature neuroscience 2022-03-14 Genetics

    Structural variants (SVs), which are genomic rearrangements of more than 50 base pairs, are an important source of genetic diversity and have been linked to many diseases.

  3. Identification of novel drug targets for Alzheimer's disease by integrating genetics and proteomes from brain and blood

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Molecular psychiatry 2021-08-11 Genetics

    Genome-wide association studies (GWASs) have discovered numerous risk genes for Alzheimer's disease (AD), but how these genes confer AD risk is challenging to decipher.

All topic tags with their study counts